Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Complete for Contact Lens Discomfort
NCT03682809Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2018
- Primary completion
- Mar 2019
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of propylene glycol-hydroxypropyl guar nanoemulsion in Contact lens discomfort (CLD), sponsored by University of Alabama at Birmingham. Started Nov 2018; status: completed.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsion
03
Conditions
Contact lens discomfort (CLD)
Beyond the preview
Go deeper on NCT03682809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682809.